Previous 10 | Next 10 |
Attributes 5,000 Percent Revenue Growth to Tablo® Hemodialysis System’s continued adoption in the acute and home settings Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity o...
MedTech company Outset Medical ( NASDAQ: OM ) stretched the post-earnings rally to the third straight session on Friday after RBC Capital Markets launched its coverage with an Outperform recommendation pointing to its undervaluation. Outset Medical ( OM ), which develo...
Outset Medical ( NASDAQ: OM ), a MedTech company focused on dialysis, climbed ~39% in the morning hours Wednesday after revising its full-year outlook to a level above the Street forecasts on the back of better-than- expected revenue for Q3 2022. For 2022, Outset Med...
Outset Medical, Inc. (OM) Q3 2022 Earnings Conference Call November 08, 2022 5:00 PM ET Company Participants Jim Mazzola – Vice President-Investor Relations Leslie Trigg – Chair and Chief Executive Officer Nabeel Ahmed – Chief Financial Offic...
The following slide deck was published by Outset Medical, Inc. in conjunction with their 2022 Q3 earnings call. For further details see: Outset Medical, Inc. 2022 Q3 - Results - Earnings Call Presentation
Revenue Grows 10.8% from Q2 to $27.8 million; Gross Margin Expands to 15.6% 2022 Revenue Guidance Raised to $111 million to $113 million Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering...
Outset Medical ( NASDAQ: OM ) has entered into two senior secured credit facilities with investment affiliates managed by SLR Capital Partners which collectively provide for borrowings of up to $300M, comprising up to a $250M term loan facility and up to a $50M asset-based rev...
Outset Medical, Inc. (Nasdaq: OM)(“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it has entered into two senior secured credit facilities with investment affiliates manag...
Findings include home dialysis patients treating with the Tablo® Hemodialysis System have lower attrition rates compared to other modalities Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company reducing the cost and complexity of ...
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the third quarter of 2022 after the close of t...
News, Short Squeeze, Breakout and More Instantly...
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the second quarter of 2024 after the close of trading on...
MONTREAL, July 24, 2024 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the “ Company ” or “ Osisko Metals ”) ( TSX-V:OM ; OTCQX:OMZNF ; FRANKFURT:0B51 ) is pleased to provide an update on the activities being carried out this summer as part of the ...